This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For wonky-tech readers, this involves using Seqster’s proprietary technology (FHIR+) to enable the flow of patient information from once-siloed data locked into legacy systems and wearable tech clouds.
For this annual report, Ordr analyzed security risks across over 500 deployments in healthcare, lifesciences, retail, and manufacturing sectors for the 12 months June 2020 through June 2021. How to protect vulnerable groups of people? How to ensure that devices are meant for well-being and not exploitation?
Tom explains, so accessibly and with evidence, how AI and the intelligent cloud can help us address a range of big challenges in health care. Importantly and impactfully, he details how to move from aspiration to execution. And you get a bonus: a Foreword written by Eric J. Topol, MD, of Scripps Research.
The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the lifesciences. Forbion invests in lifesciences companies that are active in the (bio) pharmaceutical space.
The following is a guest article by Abhishek Khandelwal, Vice President, LifeSciences at Capgemini Engineering The convergence of digital technology and healthcare has been underway for quite some time, but as we inch closer to 2024, the pace of change that this sector is experiencing is unprecedented.
This first-of-its-kind event is being hosted by the Department of Health – Abu Dhabi and aims to be a landmark platform for international collaboration on the future of healthcare and lifesciences. This likely includes areas like access to healthcare, affordability, and emerging health threats.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content